+ Watch MJN
on My Watchlist
MJN has a weak marketing strategy and an innovation pipeline that is storng long trem but less so in 2013
Moaty brand and product
Nutricuticals, I believe is the buzz word
They will underperform because competition will intensify and therefore Mead will need to increase their marketing efforts, this will increase costs. If they introduce a new formula that will allow a clear brand-differentitaiton, then they will have the opportunty to outperform. If not, then they will need to look to operations to reduce costs or expand to other markets in their goal to maintain their market share.
rocket since ipo
I have been with MJN almost since the beginning. Recently they have begun to pay dividends and appear to be very profitable and growing. Another nice defensive pick to keep the $'s coming in.
Babies will keep being born. This is a great company. Once our economic conditions change and they get rid of the debt i see a huge turn around. Could drop down a little below IPO price but it will rise. Im long on this pick two years.
A good move for BMY, but a little overpriced for now even if babies do have to eat during recessions.
Babies gotta eat! ;)
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions